AACR Events and Activities – TEST

More than 500 people participated in the AACR Runners for Research 5K Run/Walk in Atlanta’s Centennial Park on March 30. The event was held in conjunction with the AACR Annual Meeting 2019.

Mandi da Silva, a cancer survivor, holds the trophy she earned as top individual fundraiser. She is pictured with Sallie Cassel of Miltenyi Biotec, an AACR supporter.

Team members of AstraZeneca receive their trophy for top fundraising team and largest participating team.

AACR past president Elizabeth M. Jaffee, MD, stands with Mitch Stoller, AACR Foundation chief philanthropic officer and vice president of development.

Panelists discuss cancer risk reduction during “Progress and Promise Against Cancer,” a public education event presented by the AACR March 30 at Morehouse School of Medicine in Atlanta. The event was held in conjunction with the AACR Annual Meeting 2019.

An attendee at the AACR public education event asks a question during a panel discussion.

Brian M. Rivers, PhD, MPH, director of the Cancer Health Equity Institute at Morehouse School of Medicine and chair of the AACR’s Minorities in Cancer Research group, speaks at the public education event.

Walter J. Curran Jr., MD, director of the Winship Cancer Institute at Emory University in Atlanta, makes a point during a panel discussion at the public education event as Elaine R. Mardis, PhD, AACR president and co-executive director of the Institute for Genomic Medicine at Nationwide Children’s Hospital in Columbus, Ohio, listens.

Shafiq A. Khan, PhD, director of the Center for Cancer Research and Therapeutic Development at Clark Atlanta University, speaks at the public education event.

Charles L. Sawyers, MD, AACR past president and chair of the AACR Project GENIE Steering Committee, describes AACR Project GENIE to members of the Cosmos Club in Washington, D.C., in fall 2018. AACR Project GENIE is a registry of clinical-grade genomic and clinical outcomes data.

Representatives from the pharmaceutical industry and AACR staff attend the annual AACR Industry Roundtable in Phoenix last fall. Participants discussed ways to safely accelerate the development of new treatments for cancer patients.